IPSC

Century Therapeutics Inc

IPSC.US centurytx.com + Research + Basket
CIK 0001850119
Employees 78
Phone 267 817 5790
Fiscal year end December
IPO Jun 18, 2021
Address 25 North 38th Street, Philadelphia, PA, United States, 19104
1.46
-0.04 (-2.67%)
USD · NASDAQ
52-week range
0.44
3.04
Trading at 39% of the 52-week range
Market Cap
271.61M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
1.29
Div. Yield
N/A
% Institutions
87.44%
% Insiders
8.14%

1 Year

+153.2%

3 Year

+9.0%

10 Year

-93.6%
Description

Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoimmune diseases; and CNTY-101, an allogeneic, iPSC-derived CAR-iNK cell therapy with six precision gene edits engineered to express CD19 CAR, with Allo-Evasion 1.0 edits designed for the treatment of CD19 for B-cell mediated autoimmune diseases. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Actions

Add an action for IPSC.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Brent Pfeiffenberger M.B.A., Pharm.D. President, CEO & Chairman 1978
Dr. Gregory Russotti Ph.D. Chief Technology & Manufacturing Officer 1967
Dr. Chad A. Cowan Ph.D. Chief Scientific Officer 1972
Mr. Douglas Carr CPA Senior VP of Finance & Operations, Principal Financial Officer and Secretary NA
Krista Kauppinen J.D., Ph.D. VP, General Counsel & Head of Intellectual Property NA
Ms. Megan Bilson Chief People Officer NA
Michael Naso Ph.D. Senior VP of Cell Engineering NA
Ms. Elizabeth Devlin VP & Head of Development NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Mar 12, 2026 Gregory Russotti N/A Sale 10.08K $2.55 $25.69K SEC
Mar 12, 2026 Douglas Carr N/A Sale 7.04K $2.55 $17.96K SEC
Mar 09, 2026 Gregory Russotti N/A Sale 479.00 $2.54 $1.22K SEC
Feb 03, 2026 Douglas Carr N/A Sale 323.00 $1.82 $587.86 SEC
Dec 22, 2025 Chad Cowan N/A Purchase 58.06K $0.85 $49.35K SEC
Dec 12, 2025 Brent Pfeiffenberger N/A Purchase 52.00K $0.58 $30.16K SEC
Dec 08, 2025 Douglas Carr N/A Sale 257.00 $0.53 $136.21 SEC
Dec 08, 2025 Gregory Russotti N/A Sale 526.00 $0.53 $278.78 SEC
Nov 19, 2025 Brent Pfeiffenberger N/A Purchase 35.00K $0.50 $17.50K SEC
Nov 17, 2025 Brent Pfeiffenberger N/A Sale 32.46K $0.45 $14.61K SEC
Nov 17, 2025 Brent Pfeiffenberger N/A Sale 32.46K $0.45 $14.61K SEC
Nov 03, 2025 Douglas Carr N/A Sale 292.00 $0.59 $172.28 SEC
Sep 08, 2025 Brent Pfeiffenberger N/A Sale 488.00 $0.50 $244.00 SEC
Sep 08, 2025 Douglas Carr N/A Sale 263.00 $0.50 $131.50 SEC
Sep 08, 2025 Gregory Russotti N/A Sale 539.00 $0.50 $269.50 SEC
Jun 09, 2025 Adrienne Farid N/A Sale 552.00 $0.62 $342.24 SEC
Jun 09, 2025 Brent Pfeiffenberger N/A Sale 475.00 $0.62 $294.50 SEC
Jun 09, 2025 Douglas Carr N/A Sale 4.90K $0.62 $3.04K SEC
Jun 09, 2025 Gregory Russotti N/A Sale 526.00 $0.62 $326.12 SEC
May 05, 2025 Adrienne Farid N/A Sale 1.02K $0.55 $563.20 SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
RA Capital Management, LLC 17.75M Jun 30, 2026 9.81% $0.38 0.00%
TCG Crossover Management, LLC 17.75M Jun 30, 2026 9.81% $1.04 0.00%
Versant Venture Management LLC 12.17M Jun 30, 2026 6.72% $18.33 0.00%
Deep Track Capital, LP 9.46M Jun 30, 2026 5.23% $0.34 -0.26%
VR Adviser, LLC 8.70M Jun 30, 2026 4.80% $0.65 0.00%
COMMODORE CAPITAL LP 8.70M Jun 30, 2026 4.80% $1.27 0.00%
RTW INVESTMENTS, LLC 8.70M Jun 30, 2026 4.80% $0.18 0.00%
BlackRock Inc 8.09M Jun 30, 2026 4.47% $0.00 430.81%
Vanguard Capital Management, LLC 5.70M Jun 30, 2026 3.15% $0.00 0.31%
Balyasny Asset Management LLC 5.52M Jun 30, 2026 3.05% $0.02 10.07%
Point72 Asset Management, L.P. 4.98M Jun 30, 2026 2.75% $0.01 -16.50%
Seven Fleet Capital Management LP 4.35M Jun 30, 2026 2.40% $1.76 47.49%
Woodline Partners LP 4.26M Jun 30, 2026 2.35% $0.03 39.89%
Millennium Management LLC 4.19M Jun 30, 2026 2.32% $0.00 -10.12%
Trails Edge Capital Partners, LP 4.13M Jun 30, 2026 2.28% $1.61 68.77%
Spruce Street Capital LP 4.06M Jun 30, 2026 2.24% $1.95 0.00%
Adage Capital Partners Gp LLC 3.79M Jun 30, 2026 2.09% $0.01 0.00%
Geode Capital Management, LLC 2.98M Jun 30, 2026 1.65% $0.00 128.90%
Two Sigma Investments LLC 2.70M Jun 30, 2026 1.49% $0.00 13.81%
Dafna Capital Management LLC 2.40M Jun 30, 2026 1.33% $1.12 -1.39%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 4.34M 2.40% ▲ 0.00% Sep 30, 2026
2 iShares Russell 2000 ETF 3.04M 1.68% ▼ 1.14% Sep 30, 2026
3 Fidelity Small Cap Index 1.34M 0.74% ▲ 0.46% Jul 31, 2026
4 iShares Russell 2000 Value ETF 1.19M 0.66% ▲ 0.15% Sep 30, 2026
5 Vanguard Russell 2000 ETF 719.24K 0.40% ▲ 1.40% Sep 30, 2026
6 Northern Small Cap Value 549.93K 0.30% ▲ 0.00% Sep 30, 2026
7 Fidelity Extended Market Index 527.09K 0.29% ▼ 0.53% Aug 31, 2026
8 iShares Micro-Cap ETF 388.76K 0.21% ▼ 0.68% Sep 30, 2026
9 Schwab Small Cap Index 299.45K 0.17% ▲ 0.00% Sep 30, 2026
10 iShares Russell 2000 Small-Cap Idx Instl 230.38K 0.13% ▲ 0.00% Sep 30, 2026

Financial Highlights

▼
Market Cap: $271.61M
EBITDA: $-95.22M
Book Value: $1.29
Earnings/Share: $-0.96
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -23.51%
ROE (TTM): -49.65%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Valuation Metrics

Enterprise Value: $181.51M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 181.08M
Shares Float: 101.25M
% Insiders: 8.14%
% Institutions: 87.44%
Shares Short: 29.13M
Shares Short (Prior Month): 29.22M
Short Ratio: 37.58
Short % Float: 16.21%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$109.16M
Cost of Goods Sold
adjust
$-13.10M
Gross Profit
subtotal
$96.06M
SG&A
adjust
$-24.00M
R&D
adjust
$-95.67M
Operating Income
subtotal
$-15.04M
Other / Non-Operating Items
adjust
$5.46M
Net Income
subtotal
$-9.58M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IPSC.US!